Vir Biotechnology, Inc. (VIR)
13.16
-0.48
(-3.55%)
USD |
NASDAQ |
Nov 10, 16:00
13.20
+0.04
(+0.30%)
After-Hours: 20:00
Vir Biotechnology Cash from Operations (Annual) : -391.78M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -391.78M |
| December 31, 2024 | -446.35M |
| December 31, 2023 | -778.78M |
| December 31, 2022 | 1.663B |
| December 31, 2021 | -47.59M |
| Date | Value |
|---|---|
| December 31, 2020 | -190.94M |
| December 31, 2019 | -129.63M |
| December 31, 2018 | -94.10M |
| December 31, 2017 | -66.38M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Moderna, Inc. | -1.873B |
| Vaxcyte, Inc. | -655.58M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |